Skip to main content
Clinical Trials/CTRI/2021/06/034033
CTRI/2021/06/034033Not yet recruitingPhase 3

Submandibular gland sparing plus parotid sparing versus parotid sparing alone using volumetric modulated arc therapy (VMAT) in head and neck squamous cell carcinomas - a single blind phase 3 randomized controlled trial

JIPMER0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor
JIPMER

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. Patients over 18 years of age
  • 2. Patients with ECOG performance status 0 - 2
  • 3. Patients of squamous cell carcinoma of the
  • head and neck planned for radical radiation with or without concurrent chemotherapy treated with volumetric modulated arc radiotherapy

Exclusion Criteria

  • 1. Patients with previous history of radiotherapy to head and neck
  • 2. Patients with T1N0M0 carcinoma glottis
  • 3. Patients with carcinoma of the head and
  • neck in whom the submandibular glands are enclosed completely in the clinical target volume.
  • 4. Tumour involvement of both the submandibular glands
  • 5. Preâ??existing salivary gland disease
  • 6. Previous or concurrent illness that would
  • compromise completion of treatment or
  • 7. Patient receiving prophylactic amifostine or pilocarpine

Investigators

Sponsor
JIPMER

Similar Trials